Introduction
Macrophages comprise a diverse group of cells that are found in all tissues and demonstrate remarkably diverse functions [1] [2] [3] . Tissue macrophages are derived from either circulating blood monocytes that originate in the bone marrow, or embryonic precursors that establish residence within tissues and can be maintained independent of bone marrow progenitors [1, 4] . Macrophage functions range from supporting development, the maintenance of homeostasis, immune surveillance and regulation of tissue remodeling and repair [1] . These professional phagocytes play key roles initiating inflammation and orchestrating its resolution, as seen by the spectrum of macrophage "activation states" [3] . In addition to classic macrophage functions, recent investigation has dem-onstrated that macrophages are capable of producing extracellular traps (ETs).
An initial description of neutrophil extracellular traps (NETs) appeared in 2004, and this discovery was quickly followed by description of a new, programmed cell death pathway termed "ETosis" [5] [6] [7] . ETosis comprises a unique series of cellular events by which nuclear contents, including chromatin, mix with cellular proteins and are then extruded from the cell body to form extracellular structures capable of "trapping" and killing microorganisms [5] [6] [7] . Since the original report about neutrophils, other leukocytes including mast cells, eosinophils, and basophils are now known to produce "extracellular trap" structures [8] [9] [10] [11] [12] . ETs have been implicated in diverse disease states ranging from conditions of aseptic inflammation, such as gout, to vascular disorders including preeclampsia and thrombosis [13] [14] [15] [16] . Inadequate resolution and degradation of these structures is also a topic of recent research; prolonged exposure of self-antigens comprising ETs can result in autoimmune diseases including systemic lupus erythematosus (SLE) and antineutrophil cytoplasmic autoantibodies (ANCA)-associated vasculitis [17, 18] .
As macrophage functions are vital to host immune defense and tissue homeostasis, we sought to understand the role of macrophage and monocyte ETs (METs) in the context of host defense and disease states. We conducted a structured, scoping review to assess the current literature regarding the diversity of macrophages known to produce ETs, the identification of METs, the proposed functions, and the mechanisms by which macrophage ETosis (METosis) may occur. Data regarding ETs produced by neutrophils and other leukocytes have been reviewed elsewhere and were excluded from this review [19, 20] .
Methods
We performed a scoping review based on methods described by Arksey and O'Malley [21] . The central research question was: "What is known from the existing literature about ETs produced by monocytes or macrophages?" To address this, we searched for and reviewed papers with the following inclusion criterion: English language primary studies that provided some evaluation of monocytes or tissue differentiated macrophages for the ability to produce ETs. For the purpose of this review, we refer to both monocyte and macrophage ETs as "METs" and the process of extruding these structures as "METosis." These studies were not limited to human cells.
Our search was conducted using PubMed, with the search phrase: monocyte OR macrophage AND extracellular traps(s). The last search for new manuscripts was performed on 30 March 2017. The search is summarized in Figure 1 . We identified additional studies via the references of the reviewed articles. Further review to include/exclude identified articles consisted of reading the abstracts. If an article appeared relevant, but no inclusion criteria could be established, the full article was reviewed to determine if it satisfied the inclusion criterion.
Results

Defining and Identifying METs
The original description of NETs included high-resolution scanning electron microscopy (SEM) imaging; with this modality, Brinkmann et al. [5] identified fibers that were 15-17 nm in diameter and beaded with globular domains. Using immunofluorescence staining, this study determined that these globular domains contained proteins from neutrophil azurophilic, secondary, and tertiary granules including elastase, myeloperoxidase (MPO), lactoferrin, and gelatinase. Interestingly, these extracellular fibers did not contain cytoskeleton components or other cytoplasmic proteins. DNA was found to be the major structural component of these fibers, demonstrated by staining with DNA intercalating dyes and the destruction of these structures when treated with DNase. The time course by which cells undergo ETosis seems to be variable. The original description of NETs demonstrated rapid release of extracellular DNA that occurred in as little as 10 min following stimulation with phorbol myristate acetate (PMA), but later reports have suggested ETosis could take several hours [5, 6] . Yousefi et al. [9] described DNA release from eosinophils within 5 min of stimulation with complement component C5a or lipopolysaccharide (LPS), and the maximum effect, measured as fluorescence of a cell-impermeable DNA-staining dye, occurred within 30 min. METosis has been described as a rapid process that can occur in <30 min [22, 23] .
In order to identify METs, most studies utilize either SEM, looking for fibers similar to those described by Brinkmann et al. [5] Hoechst, visualized by scanning laser confocal microscopy. These dyes have also been used to construct spectofluorometric assays as an effort to quantify MET release by measuring fluorescence staining of extracellular DNA [6, 24, 25] . Typical definitions of METs, like NETs, include extracellular fibers composed of DNA that extend outside the bounds of the cell and are degraded by treatment with DNase I or micrococcal nuclease (Fig. 2) . Additional verification that proposed structures are ETs can be obtained by staining for known ET components such as histones, elastase, or MPO. Elastase, often considered a neutrophil-specific marker, has been identified in the METs of human peripheral-blood monocytes and in THP-1 macrophage-like cells [22, 26] . Similarly, MPO has been identified in the METs of diverse macrophage populations including human glomerular macrophages, human peripheral-blood monocytes, THP-1 macrophage-like cells, murine J774A.1 macrophage-like cells, bovine monocytes, and caprine monocytes [22, 23, [26] [27] [28] [29] (Table 1) .
Factors That Influence MET Release
As is the case with NETs, diverse pathogens and chemical stimuli have been noted to induce METs (Table 2 ). In addition to live bacterial cells, Wong and Jacobs [30] described that particular virulence factors such as the My cobacterium tuberculosis secretion system, ESX-1, may specifically contribute to MET release by human peripheral-blood monocyte-derived macrophages, a result that was augmented in the presence of other chemical activators including interferon-γ. Aulik et al. [25] 
noted that
Mannheimia haemolytica infection of bovine monocytederived macrophages led to MET release in a leukotoxindependent manner as infection with leukotoxin-deficient M. haemolytica cells did not result in MET release. Several publications have noted that the proinflammatory mediators that stimulate generation of reactive oxygen species (ROS) induce METs, though this finding is not consistent across all cell types and experimental conditions [25, 31] . Liu et al. [28] demonstrated that treatment of mouse macrophage-like J774A.1 cells or primary mouse peritoneal macrophages with PMA, hydrogen peroxide, interferon-γ (100 U/mL), or macrophage colony-stimulating factor (25 ng/mL) did not result in MET release, but that infection with Candida albicans or Esche richia coli was able to stimulate METosis. Based on this evidence, the authors suggested that the extrusion of MET structures from these cells occurred by a ROS-independent mechanism.
Despite the great diversity of tissue macrophages, few studies currently exist regarding the different types of macrophages that respond to pathogens with MET release (Table 1) . Knowledge is also limited regarding why some macrophages undergo METosis while others do not. For instance, Bonne-Année et al. [32] noted that although human monocyte-derived macrophages produced METs in response to Strongyloides stercoralis infection, mouse peritoneal macrophages did not, despite the fact that both human and mouse neutrophils produced NETs during infection. Similarly, Schorn et al. [10] reported that neutrophils, basophils, and eosinophils responded to monosodium urate crystals in gouty arthritis [22] were not able to demonstrate similar responses with human peripheral-blood monocytes. Current evidence is insufficient to determine if the differential responses are due to experimental conditions or if some types of macrophages are inherently more prone to METosis.
Aside from the interactions between macrophages and specific microorganisms, other factors including the cellular environment and polarization state may alter a macrophage's ability to undergo METosis. As for macrophages, the neutrophil literature reveals a growing appreciation of distinct neutrophil subsets that play particular roles in immunity and disease pathogenesis. These subsets, including proinflammatory, antitumorigenic N1 and tumorigenic N2, represent spectrums of cellular phenotypes that differ in their morphological and functional properties [33] . Type I interferons have recently been shown to promote a proinflammatory subset of neutrophils (N1, antitumorigenic) which display an enhanced ability to form NETs [34] . Likewise, Shrestha et al. [35] used retinoic acid to drive neutrophil nuclear hypersegmentation, a characteristic finding of N1 cell morphology, and found that retinoic acid treatment also resulted in the augmented release of NETs in response to PMA stimulation. In both studies, the NET-producing, N1 neutrophils also exhibited an increased capacity for cytotoxicity against cancer cells. Shrestha et al. [35] demonstrated that the addition of DNase reversed this effect, suggesting an antitumor role for NETs. Additionally, Villanueva et al. [36] demonstrated that a subset of "low-density granulocytes" isolated from patients with SLE had a greater capacity to produce NETs than normal-density neutrophils from patients with SLE or control neutrophils from patients without SLE. By producing a higher proportion of NETs, these cells may provide increased exposure of autoantigens and have an increased capacity to kill endothelial cells, driving disease pathogenesis.
Macrophages are known to function on a spectrum of activated phenotypes, or, polarization states [3] . Only 1 report to date specifically investigated how macrophage polarization may influence METosis. Nakazawa et al. [37] made the observation that PMA differentiated THP-1 cells polarized toward an inflammatory M1 activation state (treated with 20 ng/mL IFN-γ and 1 mg/mL LPS for 6 h), but not the anti-inflammatory/prohealing M2 state (treated with 20 ng/mL IL-4 for 24 h), resulted in extracellular DNA release when exposed to NET material. Of note, the authors did not specifically label this extracellular DNA release as METs, but their findings suggest that this extracellular DNA extended beyond cellular boundaries and originated from the macrophages, despite noting that the DNA release was "less drastic" than that seen by neutrophils undergoing ETosis. They found similar results with peripheral-blood mononuclear cells differentiated to polarized macrophages after 7 days of incubation with 10 ng/mL of GM-CSF (M1) or M-CSF (M2). Interestingly, DNA release by THP-1 macrophage-like cells was specific to the interaction with NETs, as macrophage extracellular DNA release was not stimulated by interactions with neutrophils undergoing other types of cell death.
Changes in the cellular environment might also alter macrophage behavior. Bryukhin and Shopova [38] used a rat model of liver injury, which has been shown to depress immune function including monocyte migration and phagocytic activity, to demonstrate that alveolar macrophages and peripheral-blood monocytes taken from the pups of mothers with drug-induced hepatitis were impaired in MET formation and bactericidal activity. Their work suggests that cellular programming or environmental signals may modify the ability of macrophage to complete METosis. Vega et al. [39] demonstrated that mouse J774A.1 and RAW264.7 macrophage-like cells undergoing a stress response (incubation at 42 ° C for 1.5 h followed by recovery at 37 ° C) were more prone to produce METs when exposed to Streptococcus agalactiae. In their experimental conditions, S. agalactiae infection resulted in decreased ROS/RNS production and elevated levels of IL-10, which are most typically associated with ET inhibition in neutrophils. They suggested that changes in the cytoskeleton triggered by stress responses, potentially via Hsp70 and Hsp27, might lead to METosis in the absence of oxidative stress or proinflammatory mediators.
Together, these studies demonstrate that MET release can occur in response to a diverse collection of pathogens, but data are limited regarding the responses of specific types of tissue macrophages. More work is needed to better understand how polarization states and environmental signals might alter cellular function with respect to METs, and whether these changes would affect all tissue macrophages in a similar way. Future studies will be important as the functions of METs in both immunity and pathophysiology become clearer.
Functions Attributed to METs
Several functions have been attributed to NETs including trapping diverse pathogens, suppression and destruction of the bacterial toxins of trapped organisms, and bactericidal activity [5] . The bactericidal activity of NETs has been attributed to a localized, high concentration of antimicrobial peptides contained on the globules of NET fibers as DNase treatment eliminates this cidal activity [5] . Several studies have examined the fundamental question of whether METs have cidal activity for different microorganisms. In order to assess microbicidal activity, most MET killing assays compare macrophages infected with or without the presence of DNase, and compare the recovered microorganisms [24, 25] . In order to separate killing that results from MET-dependent and MET-independent mechanisms (mainly phagocytosis), some studies have used the actin cytoskeletal inhibitor, cytochalasin D, to inhibit macrophage phagocytosis [24, 28] . There have been mixed results using this technique as some groups have noted decreased MET release in cells pretreated with cytochalasin D [25, 26] . To date, there are reports of potential MET microbicidal activity against pathogens including Staphylococcus aureus, S. agalactiae, E. coli, and C. albicans [28, [38] [39] [40] . Halder et al. [22] isolated monocyte ETs by digesting immobilized traps with the restriction enzyme AluI, and then added ET material to C. albicans culture; ET material, but not monocyte chromosomal DNA, was able to inhibit fungal growth even at 30 h of incubation. Instead of employing direct counting of microorganisms, Chow et al. [31] used SYTO TM 9 and propidium iodide staining of S. aureus cells trapped within METs to demonstrate the decreased viability of bacterial cells.
In spite of the results stated above, several studies have questioned the direct bactericidal activity of METs. For example, a recent study evaluated infection of PMA-differentiated THP-1 macrophage-like cells with Mycobac teria massiliense and noted that MET release actually enhanced bacterial growth, potentially by providing a scaffold for bacterial aggregation, which facilitates survival in this organism [25] . Liu et al. [28] demonstrated that mouse J774A.1 macrophage-like cells infected with E. coli or C. albicans resulted in small but significant microbial killing attributed to METs (10-20% less organisms recovered than in cells treated with DNase and cytochalasin D), but peritoneal macrophages in similar assays did not show any significant MET microbicidal activity against either organism. Of note, in this study, the extent of microbial killing attributed to METs was considerably less than that attributed to intracellular killing.
It has been proposed that METs may act synergistically with other components of host defense. Halder et al. [22] demonstrated that human monocyte release of METs was enhanced in the presence of human serum. During infection with C. albicans in media containing serum, they used immunofluorescence staining to establish that complement factors C3b and C5b-9 were deposited onto METs. They proposed that activated complement might add microbicidal activity and allow for the enhanced opsonization and phagocytosis of organisms within ETs during the resolution of inflammatory responses [22] . Shen et al. [40] showed that the antibiotic fosfomycin may boost MET release, potentially by increasing ROS production, and enhance the total extracellular killing of S. aureus by mouse peritoneal macrophages producing METs.
One of the difficulties of these studies is successfully demonstrating that METosis and METs occur in vivo and are not an artifact of ex vivo experimental conditions. Just as NETs are now recognized in diverse tissues, METs have been identified within tissues during disease states. O'Sullivan et al. [27] evaluated renal biopsy tissues from patients with MPO-ANCA-associated glomerulonephritis. Tissues from patients with glomerulonephritis had significantly more macrophages than control tissues. The authors used immunofluorescent probes against nuclear components and MPO to identify NETs and METs, which they differentiated by the presence of neutrophil elastase (a NET marker) and CD68 positivity (a MET marker). Six of 10 biopsies from patients with glomerulonephritis were found to have MPO-containing METs. This is particularly interesting given that MPO, a component of both NETs and METs, is considered to be a major autoantigen in the development of ANCA-associated vasculitis, suggesting that macrophage and neutrophil ETs contribute to the pathophysiology of this disease. Mohanan et al. [41] examined macrophage function at "crown-like structures" in breast adipose tissue. Crownlike structures are thought to be areas where macrophages clear dying adipocytes. This study evaluated mammary adipose tissue from obese mice, and found that macrophages at crown-like structures stained strongly for PAD 2 and citrullinated histones (anti-H4Cit3) which extended from macrophage nuclei into the extracellular space. The authors proposed that these macrophages were undergoing hypercitrullination via PAD 2 as part of METosis. This report suggested that METosis in adipose tissue could be driven by TNF-α release from dying adipocytes. Proinflammatory signals may promote MET release and drive further inflammatory signals within adipose tissue, influencing macrophage infiltration and activation.
Cellular Pathways Implicated in MET Release
Identifying mechanisms by which neutrophils undergo ETosis, and subsequently release NETs, continues to be an area of active research. The "NETotic cascade" comprises several steps including cytoplasmic and nuclear swelling, vacuolization, membrane protrusion, enzyme-binding to DNA, histone citrullination and chromatin decondensation, terminating in membrane rupture and NET release [42] . During this cascade, cellular granule membranes also break down, allowing for nuclear and granular proteins to mix and for granular proteins like elastase to be found within the NETs after release [6] . Early descriptions of NETs noted that this process was dependent on the NADPH oxidase system, in which NADPH oxidase-derived ROS acted intracellularly to initiate the NET cascade via actions that include the activation of elastase, which then escapes from neutrophil azurophilic granules [42, 43] . Once released, elastase translocates to the nucleus, where it degrades histones and thereby promotes chromatin decondensation [43] . Reports have also suggested that interactions between ROS formation, cellular autophagy, and PAD 4 -dependent histone citrullination result in the collapse of intracellular membranes, allowing for chromatin decondensation and subsequent release [44] .
Alternative forms of ETosis with unique pathways are now being described. Yousefi et al. [45] reported that neutrophils primed with GM-CSF and stimulated with LPS or complement component C5a could produce NETs from mitochondrial DNA in a pathway that depended on ROS but did not result in cellular death. Pilscek et al. [46] described another alternative form of neutrophil ETosis in which nuclear DNA was deposited extracellularly via membrane vesicles, a process which was not inhibited by diphenylene iodonium, suggesting an NADPH-independent pathway.
Investigations into mechanisms of MET release have been less numerous. Reports have demonstrated that inhibitors of the NADPH-oxidase system including diphenylene iodonium reduce MET formation, although this has not been consistent across all studies [23, 25, 28, 29, 40] . King et al. [47] used a fluorescent readout of ROS production (dihydrorhodamine 123) to indicate that human alveolar macrophages producing METs had a 2-fold increase in ROS fluorescence compared to cells not forming METs. Treating alveolar macrophages with the ROS inhibitor apocinin inhibited MET release. Aulik et al. [25] established that other pathways boost intracellular ROS including treatment with glucose oxidase or PMA enhanced MET release from bovine macrophages.
As with neutrophils, there are reports of alternative pathways of METosis [26, 28] . Je et al. [26] suggested that calcium influx into PMA-differentiated THP-1 macrophage-like cells may influence MET production by means of an NADPH oxidase-independent mechanism. Treatment of THP-1 cells with 20 μM 1,2-bis(o-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid or 1 μM ethylene glycol tetraacetic acid to chelate calcium diminished, but did not eliminate, MET release. Interestingly, this report suggested that the DNA present in these METs was comDoster/Rogers/Gaddy/Aronoff J Innate Immun 2018;10:3-13 DOI: 10.1159/000480373 10 posed of nuclear and mitochondrial DNA as the authors were able to identify nuclear (ACTB, GAPDH) and mitochondrial (ATP6, NDS1) genes in the supernatants of infected cells by PCR. Similarly, Liu et al. [28] , who also proposed an ROS-independent mechanism of MET release from mouse J774A.1 macrophage-like cells, identified both mitochondrial (Atp6 and Nds1) and nuclear (Actb and Gapdh) genes via in situ hybridization and PCR amplification of the supernatants from C. albicansstimulated macrophages.
Other important steps in METosis remain poorly understood. In neutrophils, both elastase and MPO contribute to ETosis [43, 48] . Elastase promotes NET release by degrading histones and promoting chromatin decondensation, and MPO synergizes with elastase chromatin decondensation in a mechanism that is independent of enzymatic activity [43] . To date, 4 studies have evaluated if elastase and myeloperoxidase contribute to METosis. Wong and Jacobs [30] used the elastase inhibitor, Nmethoxysuccinyl-Ala-Ala-Pro-Val-chloromethyl ketone (AAPV), to block monocyte-derived macrophages infected with M. tuberculosis or S. aureus from releasing METs. Shen et al. [40] found similar results with AAPVtreated mouse peritoneal macrophages infected with S. aureus. In contrast, Je et al. [26] noted AAPV-treated THP-1 macrophage-like cells infected with M. massili ense were unaffected with regard to MET release despite elastase being identified within the MET structures. Muñoz-Caro et al. [23] inhibited MET release by bovine monocytes infected with Besnoitia besnotii trachyzoites using the MPO inhibitor, 4-aminobenzoic acid hydrazide (ABAH). These studies all suggest an active role for elastase and MPO in METosis, but it remains to be determined if the mechanisms by which these enzymes contribute actually mirror those seen in neutrophils.
Chow et al. [31] used statin drugs to implicate sterol production pathways as a potentially important mediator of MET formation. They demonstrated that MET formation was enhanced in statin-treated murine peritoneal macrophages. They found similar results using siRNA knockdown of HMG-CoA reductase; this was reversed by treatment with the HMG-CoA reductase product mevalonate. They proposed that the effect of statins to boost MET production might be mediated by intermediates of the sterol synthetic pathways, although the exact mechanism by which these intermediates may alter METosis is not well understood.
The role of cytoskeleton rearrangement in both neutrophils and macrophage ETs remains a topic of debate. Pretreatment with the actin cytoskeletal inhibitor, cytochalasin D, often used to block phagocytosis, has demonstrated the ability to decrease MET formation in some studies [25, 26] . Cytochalasin D treatment did not have a significant effect on METosis of bovine monocytes exposed to B. besnoiti or murine J774A.1 macrophage-like cells in response to E. coli or C. albicans [23, 28] . Aulik et al. [25] reported that cytochalasin D reduced the bovine peripheral-blood and alveolar macrophage METosis response to M. haemolytica and its leukotoxin, but, in this same study, cytochalasin D had no significant effect on MET release from THP-1 or RAW 264.7 macrophagelike cells in response to E. coli hemolysin. Contrary to this report, Je et al. [26] found that THP-1 macrophage-like cells treated with cytochalasin D were impaired with regard to phagocytosis and MET release in response to M. massiliense. These findings have led some authors to speculate that the phagocytosis of particular microorganisms or microbial toxins maybe an important trigger for MET formation [25, 26] .
There are also conflicting reports regarding the role of cytoskeletal inhibitors in NET biology. In the original NET description, cytochalasin D effectively prevented phagocytosis of Shigella flexneri or S. aureus but not NET release [5] . Other studies have also reported that cytoskeletal inhibitors had no effect on NET formation in response to Paracoccidioides brasiliensis or gold nanoparticles [49, 50] . Neeli et al. [51] reported that a 10 μM treatment with either the microtubule inhibitor nocodazole or cytochalasin D diminished histone deamination and NET release in response to LPS, and similar results were documented by Jerjomiceva et al. [52] using enrofloxacin-treated bovine neutrophils. The basis for the divergent results of these studies is not clear, but more research is needed to better define the role of the cytoskeleton during the processes of ETosis in neutrophils and macrophages.
A few studies have investigated the role of protein arginine deiminases (PADs) and histone hypercitrullination as an important step in METosis. PAD 4 -mediated hypercitrullination has been shown to be an important pathway during neutrophil ETosis that leads to chromatin decondensation; inhibition of this pathway impairs NET release [53] . Nakazawa et al. [37] made the observation that PAD 4 expression in PMA-differentiated THP-1 cells accompanied M1 phenotype induction; treatment of these cells with PAD 4 siRNA resulted in the inhibition of extracellular DNA release. Mohanan et al. [41] demonstrated that treatment with TNF-α resulted in histone hypercitrullination via PAD 2 in RAW 264.7 cells prior to chromatin decondensation and MET release.
Overall, the limited studies that have evaluated the steps of METosis mirror the findings of neutrophil ETosis, but there are discrepancies in the literature, particularly with regard to the role of ROS and cytoskeleton polymerization during METosis. More work is needed to further define differences in the ROS-dependent and independent pathways of METosis and also whether particular signaling pathways may favor one over the other.
Is METosis a Cell Death Pathway?
ETosis is considered to be a different cellular pathway from apoptosis as neutrophils undergoing ETosis do not demonstrate typical DNA fragmentation, lack phosphatidylserine localization to the outer leaflet of cellular membrane, and lack typical caspase activation, all hallmarks of cells undergoing apoptosis [6] . ETosis is also notably different from cellular necrosis as, in ETosis, both the nuclear and granular membranes disintegrate, while the plasma membrane is intact [6] . As noted above, reports of alternative forms of ETosis have been documented in neutrophils and eosinophils, and these suggest that not all ETosis pathways end in cell death [9, 45] .
A few studies have evaluated monocyte and macrophage viability while undergoing METosis. Using fluorescence cell staining for intracellular esterase activity and plasma membrane integrity, Chow et al. [31] revealed that staining of MET-producing RAW 264.7 macrophage-like cells was consistent with a loss of membrane integrity, suggesting that these cells were no longer viable. Vega et al. [39] used a similar approach and noted that mouse J774A.1 macrophage-like cells producing METs were dead within 3 h. Nakazawa et al. [37] used TUNEL staining to evaluate M1-polarized THP-1 cells releasing extracellular DNA after exposure to NETs. The cells demonstrated positive TUNEL staining, which contradicts a report on neutrophils that suggested that NET-producing cells are TUNEL negative [6] .
One study evaluated the role of caspase-1 in METosis. Webster et al. [54] illustrated that human peripheralblood monocytes infected with either E. coli or Klebsiella pneumoniae resulted in caspase-1 activation, which is considered part of some nonapoptotic cell death pathways, particularly pryoptosis. Inhibiting caspase-1 with the chemical z-YVAD-fmk reduced MET release. With caspase-1 activation, the authors remarked on a general loss of cell viability over the first 12 h of infection. Caspase-1, while not previously noted to be activated in neutrophil ETosis, was found to be activated in macrophages in response to NET material and the antibacterial protein LL-37 present on NET fibers [55] . It remains unclear if exposure to MET fibers could induce a similar response in surrounding macrophages, potentially driving further proinflammatory responses including METs.
The sparse data available suggest that METosis is indeed a cell death process, similar to the classic pathways in neutrophils. More work is needed to define the principal triggers and pathways that move a macrophage from other immune responses to METosis. Additional studies are also needed to differentiate the markers of different cellular death pathways, including METosis, and to clarify the conflicting data.
Area of Future Research
As the interest in METs grows, research will likely focus on differences between macrophages and other cells that produce ETs. In other leukocytes like neutrophils or basophils, macrophage functions can vary dramatically based on differentiation, microenvironment, and polarization states. As such, it may not be surprising that the current literature in this field contains many conflicting reports. Future studies will need to find ways to delineate how subtle shifts in cellular programming, such as macrophage polarization, may direct macrophages to different immune responses against pathogens. Additionally, it has yet to be explored whether METosis occurs globally in all macrophages, including specialized cells like Kupffer cells and microglia. As the NET literature has expanded broadly since the first description in 2004, it seems likely that appreciation of METs and their role in immunity and pathophysiology will continue to gain recognition and stimulate additional studies to add to our current understanding of METosis.
